Neuroone Medical Technologies (NMTC) Receivables - Net (2020 - 2026)

Neuroone Medical Technologies (NMTC) has reported Receivables - Net for 7 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Net changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $1.3 million, up 616.05% from the prior year.
• Receivables - Net slipped to $1.1 million in Q2 2026 per NMTC's latest filing, from $1.9 million in the prior quarter.
• Across five years, Receivables - Net topped out at $2.7 million in Q4 2025 and bottomed at $33237.0 in Q3 2022.
• Historically, Receivables - Net has averaged $834002.1 across 5 years, with a median of $476975.0 in 2023.
• The widest YoY moves for Receivables - Net: up 616.05% in 2025, down 42.63% in 2025.
• Over 5 years, Receivables - Net stood at $95319.0 in 2022, then jumped by 470.08% to $543399.0 in 2023, then surged by 335.94% to $2.4 million in 2024, then grew by 12.37% to $2.7 million in 2025, then slumped by 58.71% to $1.1 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $1.1 million, $1.9 million, and $2.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.